Alaunos Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Fort Lauderdale, FL
TCRT chart
What traders are saying about $TCRT
Latest postsAlaunos Therapeutics, Inc. news
- Alaunos Therapeutics Regains Nasdaq Equity Compliance; Listing to Continue
TradingView ·
- Most Active Stocks in Today's US Session
ChartMill ·
- Another Paragon spinout goes public through reverse merger
biopharmadive.com ·
- Top Midday Gainers
Yahoo Finance ·
- Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics
Yahoo Finance ·
- BC-Most Active Stocks
Yahoo Finance ·
- Paragon Labs Expands Leadership Team with Former Apogee Executives; Velaris Therapeutics Acquired by Alaunos Therapeutics, Inc.
Yahoo Finance ·
- Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules
Yahoo Finance ·
- Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study
Yahoo Finance ·
- Alaunos Reports Positive Preclinical Obesity Drug Results Across Weight, Liver, Insulin Markers
stocktwits.com ·
- Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies
Yahoo Finance ·
- Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models
Yahoo Finance ·
Alaunos Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $5,000 | $10,000 | $5,000 | $2.9M |
| Net income | -$4.2M | -$4.7M | -$4.7M | -$37.7M |
| Diluted EPS | $-2.20 | $-2.92 | $-21.97 | $-2.61 |
| Total assets (year end) | $3.0M | $2.8M | $8.3M | $64.9M |
| Cash and equivalents (year end) | $1.4M | $1.1M | $6.1M | $39.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Alaunos Therapeutics, Inc.
- Ticker
- TCRT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Fort Lauderdale, FL
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1107421
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
Frequently asked questions
What exchange is Alaunos Therapeutics, Inc. listed on?
Alaunos Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TCRT.
What industry is Alaunos Therapeutics, Inc. in?
Alaunos Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Alaunos Therapeutics, Inc. headquartered?
Alaunos Therapeutics, Inc.'s business address on file with the SEC is in Fort Lauderdale, FL.
When does Alaunos Therapeutics, Inc.'s fiscal year end?
Alaunos Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Alaunos Therapeutics, Inc. report?
Alaunos Therapeutics, Inc. reported $5,000 in revenue for calendar year 2025, according to its SEC filings.